LSE:BXP

Beximco Pharmaceuticals Limited · LSE · Healthcare · GBP · FY for 2024

Figures on this page computed 2026-11-08 12:25 UTC

Last close

n/aGBp

Market data

7.6xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
GBp
- computed
- Computed from the filing for 2024
12.7%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
GBp
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
13.1%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
GBp
- Computed from the filing for 2024
- Computed from the filing for 2024
13.8%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
GBp
- Computed from the filing for 2024
- Computed from the filing for 2024
0.13Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
GBp
- Computed from the filing for 2024
- Computed from the filing for 2024
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
GBp
- computed

6 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

All from 100

lens 2 of 9

Sales

396

2014-12-31 to 2024-06-30100 at the start396

Sales: 100.00 on 2014-12-31 to 396.11 on 2024-06-30, up 296%.

Profit

381

2014-12-31 to 2024-06-30100 at the start381

Profit: 100.00 on 2014-12-31 to 381.44 on 2024-06-30, up 281%.

Shares in issue

100.0

2014-12-31 to 2024-06-30100 at the start100.0

Shares in issue: 100.00 on 2014-12-31 to 100.00 on 2024-06-30, down 0%.

Sales is at 396, Profit is at 381, Shares in issue is at 100, against 100 in 2014.

Sales is at 396, Profit is at 381, Shares in issue is at 100, against 100 in 2014.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2024

Sales, where the first year is 100396
Source
computed
Statement
income
Fiscal year
2024
Reported in
BDT
Profit, where the first year is 100381
Source
computed
Statement
income
Fiscal year
2024
Reported in
BDT
Shares in issue, where the first year is 100100
Source
computed
Statement
income
Fiscal year
2024
Reported in
BDT